U.S. Equifax, Microstrategy, Netflix
Nov 19 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Equifax, Microstrategy and Netflix, on Tuesday.
HIGHLIGHTS
* Caseys General Stores Inc CASY.O: Jefferies raises target price to $470 from $450 |
* Equifax Inc EFX.N: JP Morgan cuts target price to $283 from $304 |
* Microstrategy Inc MSTR.O: Benchmark raises target price to $450 from $300 |
* Netflix Inc NFLX.O: Jefferies raises target price to $1,000 from $800 |
* Palo Alto Networks Inc PANW.O: Jefferies raises target price to $450 from $400 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Aclaris Therapeutics Inc ACRS.O: BTIG raises to buy from neutral |
* Aclaris Therapeutics Inc ACRS.O: Jefferies raises to buy from hold |
* Aclaris Therapeutics Inc ACRS.O: Jefferies raises target price to $7 from $2 |
* Aclaris Therapeutics Inc ACRS.O: Piper Sandler raises to overweight from neutral |
* Aclaris Therapeutics Inc ACRS.O: Piper Sandler raises target price to $13 from $3 |
* Arvinas ARVN.O: Stephens initiates coverage with overweight rating; target price $55 |
* Beacon Roofing Supply Inc BECN.O: JP Morgan raises target price to $136 from $119 |
* C4 Therapeutics CCCC.O: Stephens initiates coverage with equal-weight rating; PT $4 |
* Caseys General Stores Inc CASY.O: Jefferies raises target price to $470 from $450 |
* Catalyst Pharmaceuticals CPRX.O: Stephens initiates coverage with overweight rating; PT $35 |
* Chargepoint Holdings Inc CHPT.N: HSBC cuts target price to $1.2 from $2 |
* Copart Inc CPRT.O: JP Morgan raises target price to $60 from $55 |
* Cullinan Therapeutics Inc CGEM.O: Jonestrading raises target price to $34 from $29 |
* Dime Community Bancshares DCOM.O: Stephens raises to overweight from equal-weight |
* Dime Community Bancshares DCOM.O: Stephens raises target price to $39 from $30 |
* Enhabit Inc EHAB.N: Jefferies cuts target price to $8.25 from $8.75 |
* Equifax Inc EFX.N: JP Morgan cuts target price to $283 from $304 |
* Fennec Pharmaceuticals FENC.O: Stephens initiates coverage with overweight rating; PT $15 |
* Fortinet Inc FTNT.O: Piper Sandler raises target price to $100 from $80 |
* Franco-Nevada Corp FNV.N: UBS initiates coverage with buy rating; target price $160 |
* Ideaya Biosciences IDYA.O: Stephens initiates coverage with overweight rating; PT $51 |
* Kemper Corp KMPR.N: TD Cowen raises target price to $84 from $72 |
* Kraft Heinz KHC.O: Piper Sandler cuts to neutral from overweight |
* Kraft Heinz KHC.O: Piper Sandler cuts target price to $35 from $40 |
* Kymera Therapeutics KYMR.O: Stephens initiates coverage with overweight rating; PT $65 |
* Lovesac Co LOVE.O: Roth MKM raises target price to $35 from $31 |
* Methanex Corp MEOH.O: Piper Sandler raises target price to $71 from $68 |
* Microstrategy Inc MSTR.O: Benchmark raises target price to $450 from $300 |
* Microstrategy Inc MSTR.O: TD Cowen raises target price to $392 from $385 |
* Moderna MRNA.O: Berenberg initiates coverage with hold rating; target price $42 |
* Mosaic Co MOS.N: Berenberg raises target price to $32 from $30 |
* Netflix Inc NFLX.O: Jefferies raises target price to $1,000 from $800 |
* Netflix Inc NFLX.O: Wedbush raises target price to $950 from $800 |
* Palo Alto Networks Inc PANW.O: Jefferies raises target price to $450 from $400 |
* Plug Power Inc PLUG.O: HSBC cuts target price to $3.7 from $7.1 |
* PTC Therapeutics Inc PTCT.O: JP Morgan raises target price to $62 from $51 |
* Quantumscape Corp QS.N: HSBC raises target price to $5.3 from $4.7 |
* Quantumscape Corp QS.N: HSBC raises to hold from reduce |
* Ready Capital Corp RC.N: KBW cuts target price to $6.75 from $7 |
* Reddit RDDT.N: Piper Sandler raises target price to $150 from $115 |
* Regenxbio Inc RGNX.O: Leerink Partners raises target price to $38 from $34 |
* Suncor Energy Inc SU.TO: UBS raises target price to C$65 from C$61 |
* Vertiv Holdings Co VRT.N: Jefferies raises target price to $145 from $125 |
* Williams-Sonoma Inc WSM.N: JP Morgan raises target price to $145 from $136 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
